Chuck Stevens is the chief executive officer of COPILOT. He leverages almost three decades of bio-pharmaceutical
industry experience to lead the executive team and drive the company’s transformational HUB strategies.
Before being named CEO in 2023, he served as COPILOT’s chief operating officer, where he developed strategic
operations plans to support revenue and market share and was responsible for strategic reimbursement,
pricing, payer strategy, product distribution, medical communications, payer marketing, and HEOR modeling.
Chuck specializes in hematology, oncology, infectious diseases, addiction medicine, CNS, OA, and rare disorder products. Before joining COPILOT, Chuck served as the president of MediMedia/CHC and head of global access and commercialization at ICON and led a team of over 400 life science consultants. Prior to this, he was the vice president and general manager of PAREXEL’s reimbursement HUB, health policy, and market access consulting practice. In the past, Chuck also held commercial positions at Cephalon Oncology, Cell Therapeutics, Genetics Institute (Wyeth Oncology), and Abbott Laboratories.
Chuck is a former Captain in the United States Army and a veteran of Operation Desert Storm. He graduated from Northeastern University with a Bachelor or ARTS/SCIENCE in MAJOR. He has an MBA from Clark University, a Juris Doctor Degree from Suffolk University Law School, and attended the Massachusetts Senior Executive Program at Harvard University’s John F. Kennedy School of Government.
Dr. Moby Kazmi is the president and co-founder of COPILOT. In his role, Moby leads the development of innovative bio-pharma reimbursement HUB solutions. Moby has played a significant role in developing COPILOT's digital platform and was instrumental in developing a design that provides healthcare professionals and bio-pharma clients with instantaneous data regarding patient insurance approval. His work has led to COPILOT's services becoming a cornerstone in the commercial success of many essential drug and device products.
Moby established and drives COPILOT Cares, a global philanthropic initiative benefiting underprivileged children and families. One of COPILOT Cares' critical investments is the installation of over 600 hand pumps to provide clean water across India, Bangladesh, Pakistan, and Sri Lanka.
Before COPILOT, Moby co-founded CareMed Specialty Pharmacy, which was recognized as one of the nation's fastest-growing, privately held companies by Inc. Magazine and acquired by PharMerica.
In 2021, Moby was named one of the Orlando Business Journal's 2021 "CEOs of the Year" and recognized as one of the National Minority Quality Forum's top "Forty Under 40" Leaders in Minority Health. In 2023, Ernst and Young recognized Moby as a 2023 Entrepreneur of the Year finalist. Today, he serves on the Board of Directors for AdventHealth for Children, Bali Memorial Trust, and Helping Hands Foundation.
Moby earned his Medical Doctorate Degree from Avalon School of Medicine and his undergraduate degree in psychology from Stony Brook University.
Scott Holden is COPILOT's chief financial officer. He joined the company in 2023 and brings nearly 30 years of healthcare and life science industry experience to the organization. Scott provides financial leadership, direction, and analysis across the organization as COPILOT grows and supports its life science partners by creating functional reimbursement HUB services. Scott also oversees company revenue, reviewing department budgets, forecasting, managing partnerships, analyzing spending, and improving employee benefits.
Before COPILOT, Scott served in several financial leadership roles across various aspects of the industry, both on the service and support side, as well as RandD and commercial manufacturing. Most recently, Scott was the senior director of financial planning and analysis at Marinus Pharmaceuticals, providing economic direction, insight, analysis, and scenario modeling for the successful launch of Marinus' first commercial product, Ztalmy. He also served in a similar role at Strongbridge Biopharma as director of FP&A before its acquisition by Xeris Pharmaceuticals in 2021. In the past, Scott also served as division principal of finance at ICON Clinical Research, the vice president of finance and controller at Medimedia Pharma Solutions, and a financial leader at Johnson and Johnson and Wyeth (Pfizer). Earlier in his career, he also worked in auditing at PriceWaterhouse (now PWC).
Scott earned a graduate degree and a bachelor's degree in business administration and accounting from Bucknell University and an MBA in marketing from Fairleigh Dickinson University.
Ty Markey is the chief technology officer at COPILOT. He is one of the company's founding employees and the principal architect of COPILOT's proprietary HUB technology platform. In his role, Ty lends his two decades of IT and technology innovation experience to develop and enable efficient information processing, communication technologies, and IT policies that support security, and disaster recovery. Before being named CTO, Ty was COPILOT's director of information technology, managing HUB solutions software and web development.
Before COPILOT, Ty worked at CareMed Specialty Pharmacy to build out the infrastructure for an integrated HUB services. Prior to this, he worked at Meditab Software as Division Manager, Telephony where he established and maintained global computer network infrastructure and security. He led the telephony division at SuiteRx as well, overseeing the telephony department for a pharmaceutical software manufacturer. Earlier in his career, he worked at Intuit.
Ty attended the University of California at Berkeley and Northern Arizona University.
Matt McGrath is the senior vice president of client services at COPILOT. For almost a decade, he has led multiple workstreams across client relations, including account management and business development, while supporting the launch and transition of several HUB programs.
Before COPILOT, Matt was an account management executive at CMO Club, responsible for managing billion-dollar brand engagement and maintaining C-suite relationships. He also gained extensive healthcare marketing experience supporting client engagement at Medidata Solutions and Palio Communications (Syneos). In the past, Matt supported several brands across various disease categories, including osteoarthritis, dermatology, pain management, diabetes, and urology. He actively supports COPILOT’s clients, overseeing a team of dedicated professionals who work to make the client integration process seamless, on time, and on budget.
Matt earned a Bachelor of Arts in marketing from Roger Williams University.
Caleb began his career in health policy working for the Massachusetts Legislature, and drafted legislation
that expanded healthcare access and prescription drug benefit to seniors. He next served as a Special
Assistant at the Centers for Medicare and Medicaid Services (“CMS”) in Washington DC. In this position,
he advised the Offices of Regulatory Affairs and Administrator on payment policy, and managing the clearance
of all regulations within the U.S. Department of Health and Human Services, the White House’s Office of
Management and Budget, and the Office of Federal Register.
Upon leaving CMS in 2005, DesRosiers spent five years in the life science industry—Pfizer, and Roche—supporting brand teams cross-functional payment policy, advocacy, managed care and commercial initiatives. Since 2010, DesRosiers has provided strategic market access, and payment policy advisory consulting to life science and healthcare technology companies. DesRosiers is currently the Commercial Operations Advisor at COPILOT spearheading business development, marketing, and policy. In addition, he is a Senior Principal at Valuate Healthcare Consultancy—a company of Entrée Health a leading market access agency within Omnicom Healthcare Group and its parent company Omnicom Group (NYSE: OMC).
Prior to his executive roles at COPILOT, and Valuate, Caleb was the Chief Strategy Office of PrescribeWellness, a pharmacy SaaS company, and was the EVP of Payer Relations and Legal Affairs at CareMed Specialty Pharmacy—a company of PharMerica, where he successfully advised the founders on strategic partnership initiatives.
DesRosiers serves on the board of Daxor Corporation (NASDAQ: DXR), the Health Alliance Plan of Michigan—a company of Henry Ford Health System, and advisory board of TruLite Health, and Brightwood Capital Advisors. He served on the boards of Affinity Health Plan, Health Pointe of New York, Trusted Health Plan of Michigan, the Primary Care Development Corporation, and advisory board of PrescribeWellness.
B.A. in Public Administration and Law from Suffolk University.
Master’s in Public Administration and Law from Suffolk University.
Alicia is an expert in commercial patient HUB operations and new product launches with over 10 years of
global experience in creating, developing, and managing patient assistance programs in multiple therapeutic areas.
Prior to coming to COPILOT, Alicia’s most recent experience includes her expertise in the cell and gene space. While at Kite, A Gilead Company, Alicia was a key player for the development of the end-to-end process, patient enrollment to product delivery, of getting the first approved CAR-T therapy for adults to transplant centers both in the US and ex-US. At Gamida Cell, Alicia was responsible for creating and overseeing end-to-end patient journey, with supporting operational efficiencies, leading the project management of system and process validations in preparation of FDA submission.
Alicia is committed to continuing her journey in improving operational efficiency in patient services and creating unique developments to ensure speed to therapy for patient access. She is a patient advocate in her community, with the goal of decreasing the gap in the health disparities.
Graduated with B.S. degree in Health Education from The University of Central Arkansas.
M.S. in Health Administration/Education from The University of Central Arkansas.
Marlon is an accomplished business development executive with extensive experience in patient and
pharmaceutical services. At COPILOT, he leads the Business Development team and is responsible for
developing and executing sales strategies, building relationships with life science companies and
strategic partners, and driving business growth.
Marlon has over 25 years of experience in the healthcare industry, focusing on pharmaceuticals, biotechnology, specialty pharmacy, infusion management, and patient support services. He is a results-oriented leader who delivers innovative solutions that improve patient outcomes. In addition, Marlon's extensive provider and patient-centric commercial launch and leadership experience make him an asset to COPILOT.
Before joining COPILOT, Marlon worked at AmerisourceBergen's LASH Group and Biopharma Services as Vice President of Business Development, Strategic Account Management, Sales Operation, and Sales Enablement. Marlon has also worked at AppianRx, a manufacturer of patient support services and specialty pharmacy provider, where he served as SVP of Sales and Marketing. Before that, Marlon was the Vice President of Commercial Operations at Iroko Pharmaceuticals and has held other senior commercial leadership roles at Allergan (Map Pharma), Sunovion, and Rhone-Poulenc Rorer.
Master of Science in Strategic Management from Stevens Institute of Technology, Hoboken, NJ.
Undergraduate degree in Marketing from Seton Hall University, South Orange, NJ.
Judy has worked with COPILOT’s senior leadership team for nearly a decade, originally joining CareMed Specialty Pharmacy in 2011. She began as a Recruiting Assistant and went on to become the Human Resources Staffing Manager. She transitioned to COPILOT in 2017 and helped expand the Human Resources department, developing recruitment, onboarding and training processes to support HUB operations.
Judy is responsible for staffing, engagement and benefits. She leads the development and strategic placement of personnel. She guides the Human Resources team, manages relationships between leaders and all levels of staff, ensures compliance and advises on all employment matters.
Prior to COPILOT, she was an event coordinator and coached children in educational sports programs. Judy studied writing, literature, and the arts at Brandeis University, and The New School in New York. She uses her strong communication, creativity and baking skills to lift spirits, raise awareness for charitable causes and positively impact the company and the surrounding community.
Graduated in writing, literature, and the arts from Brandeis University, and The New School in New York.
Edmanuel (Eddie) has been a part of the COPILOT family for over 8 years. He currently serves as
the Director of Operations and Performance. In this role, Eddie works with Team Leads and Supervisors to audit
and understand operations and processes so that, as an organization, COPILOT can continue to change and grow.
He began his career in healthcare as a pharmacy technician and has experience in retail, Long Term Care, and
Specialty Pharmacies. This has allowed him to build an expansive knowledge base on pharmacy benefits and health care in general.
In these positions, he has built a love for quick turnaround time and service.
In addition to monitoring daily operations, Eddie has been instrumental with new product launches.
When he isn't fulfilling his duties at COPILOT, Edmanuel enjoys his time off with his wife and son.
Melina Cortes-Nmili is the vice president of sales and marketing at COPILOT and a senior leadership team member.
In her role, Melina drives and implements sales and marketing efforts, leveraging her passion for caregiver
advocacy and two decades of expertise across multiple specialty therapeutic areas.
Prior to joining COPILOT, Melina served as vice president of specialty programs and consulting for Prime Therapeutics, where she rebuilt and transformed the business unit and created a client consulting offering. Before this, she was the vice president of sales and marketing at Apotheco Pharmacy Group, creating and executing brand strategies and leading sales training programs. At Diplomat, Melina developed a digital patient ecosystem for patients and their caregivers to stay compliant and adherent to therapy. Earlier in her career, Melina held marketing and product roles at Optum and Genzyme.
Melina earned a Bachelor of Arts in business administration from the University of Massachusetts at Boston and an MBA from Northeastern University. In October 2023, she received the Influential Hispanic Woman award, honoring Latina women making a difference in business. She is a valued mentor and an active force within several local Boston organizations that promote the development of women and young professionals. Melina is also an acclaimed fashion designer, securing the title “Best Clothing Designer 2023” from Boston Magazine.
Anne Chiotti, Pharm.D is the Clinical Pharmacist of COPILOT Provider Support Services in Scottsdale, AZ.
In addition to managing all non-dispensing pharmacy operations, Anne provides support to clients, healthcare
professionals, and patients through leading the development of adherence support programs for HUB products.
Having lost two young cousins and countless loved ones to Cancer over the past 2 decades, she finds passion
in providing patient care services to those relying on specialty medications (especially those with Oncology indications).
This inspired her work as a Pharmacist at the Yuma Regional Cancer Center in Yuma, AZ and as a Pharmacy Intern at The James Cancer Hospital and Solove Research Institute in Columbus, OH. She holds a Doctor of Pharmacy from The Ohio State University, a M.S. degree from Roswell Park Cancer Institute (Buffalo, NY) and a B.S. degree in Pharmaceutical Science from The State University of New York at Buffalo.
Doctor of Pharmacy from The Ohio State University.
M.S. degree from Roswell Park Cancer Institute (Buffalo, NY).
B.S. degree in Pharmaceutical Science from The State University of New York at Buffalo.